What is the next earnings date for ANABV stock?
ANAPTYSBIO INC- W/I (ANABV) will report earnings on 2026-05-07, after the market close.
ANAPTYSBIO INC- W/I (ANABV) Forecast, Price Target & Analyst Ratings
NASDAQ:ANABV • US0327241065
Current stock price
43.8 USD
+0.8 (+1.86%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ANAPTYSBIO INC- W/I (ANABV).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 7, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.96
- Revenue Estimate
- 29.123M
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $43.80 to mean target of N/A, Based on 19 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
85.26%
ANABV was analyzed by 19 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ANABV.
In the previous month the buy percentage consensus was at a similar level.
ANABV was analyzed by 19 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 7, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.96
- Revenue Estimate
- 29.123M
- Revenue Q2Q
- 4.87%
- EPS Q2Q
- 24.78%
- Number of Analysts
- 13
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
ANABV is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is -0.96 USD and the consensus revenue estimate is 29.12M USD.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 17.157M 66.73% | 91.28M 432.03% | 234.603M 157.01% | 138.3M -41.05% | 210.41M 52.14% | 272.5M 29.51% | 326.32M 19.75% | 499.22M 52.98% | 709.19M 42.06% | 881.18M 24.25% | 1.129B 28.12% | |
| EBITDA YoY % growth | -156.42M -36.65% | -114.343M 26.90% | 48.455M 142.38% | 10.2M -78.95% | 253.98M 2,390.00% | -75.48M -129.72% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -157.072M -36.41% | -114.949M 26.82% | 47.896M 141.67% | -84.512M -276.45% | -129.86M -53.66% | -55.227M 57.47% | -77.496M -40.32% | 103.17M 233.13% | 350.37M 239.60% | 507.24M 44.77% | 785.73M 54.90% | |
| Operating Margin | -915.50% | -125.93% | 20.42% | -61.11% | -61.72% | -20.27% | -23.75% | 20.67% | 49.40% | 57.56% | 69.60% | |
| EPS YoY % growth | -6.08 -33.04% | -5.21 14.31% | -0.52 90.02% | -4.11 -690.67% | -4.33 -5.24% | -3.82 11.64% | -1.83 52.24% | 3.86 311.17% | 7.69 99.47% | 10.89 41.64% | 15.24 39.89% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.96 24.78% | -0.96 28.02% | -1.08 -308.17% | -1.20 -175.79% | -0.98 -1.32% | -0.93 3.63% | -0.89 17.61% | -0.68 43.10% |
| Revenue Q2Q % growth | 29.123M 4.87% | 27.727M 24.54% | 31.386M -58.88% | 36.391M -66.38% | 29.733M 2.09% | 34.323M 23.79% | 39.423M 25.61% | 45.329M 24.56% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -20.371M 26.03% | -20.317M 22.36% | -21.589M -162.21% | -26.704M -139.92% | -26.668M -30.91% | -24.917M -22.64% | -23.065M -6.84% | -12.507M 53.17% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-94.45%
EPS Next 5 Year
56.59%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
8.23%
Revenue Next 5 Year
18.35%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-73.93%
EBIT Next 5 Year
N/A
ANAPTYSBIO INC- W/I / ANABV Forecast FAQ
Can you provide the consensus estimates for ANAPTYSBIO INC- W/I next earnings?
The consensus EPS estimate for the next earnings of ANAPTYSBIO INC- W/I (ANABV) is -0.96 USD and the consensus revenue estimate is 29.12M USD.
What is the expected long term growth rate for ANAPTYSBIO INC- W/I (ANABV)?
The expected long term growth rate for ANAPTYSBIO INC- W/I (ANABV) is 8.23%.